Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rhythm Biosciences Ltd has successfully raised $3.5 million through a strong share placement, priced at $0.10 per share, to further develop and commercialize its ColoSTAT® Multiplex colorectal cancer test. The placement attracted significant interest from new institutional and sophisticated investors, reflecting confidence in the company’s innovative cancer diagnostics technology. The funds will support the finalization of the test kit, clinical validation, and expansion of their R&D pipeline.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.